Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Warfarin pharmacogenetic cohort study after heart valve replacement
ChiCTR-OCC-10000778Phase 4Completed
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of warfarin in Cardiac valve disease (VHD), sponsored by Guangdong Provincial People's Hospital. Primary endpoint: International normalized ratio. Started Jan 2008; status: completed.
02
Drugs
warfarin
03
Conditions
Cardiac valve disease (VHD)
Beyond the preview
Go deeper on ChiCTR-OCC-10000778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OCC-10000778.